advertisement
Laser Treatment Editor's Selection
17 comments · all topics
Gonioscopy-free DSLT: a worthy alternative to conventional SLT?
Tony Realini on: Randomized Noninferiority Trial of Direct Selective Laser Trabeculoplasty in Open-Angle Glaucoma and Ocular Hypertension: GLAUrious Study IGR 25-4 | 2026
SLT after drops: what do LiGHT trial data tell us?
Tony Realini on: Selective Laser Trabeculoplasty After Medical Treatment for Glaucoma or Ocular Hypertension IGR 25-2 | 2025
Optimizing SLT Performance
Abdus Samad Ansari & Gus Gazzard on: Optimal Performance of Selective Laser Trabeculoplasty: Results from the Swedish Optimal SLT Multicenter Randomized Controlled Trial IGR 24-3 | 2024
Latanoprost, SLT and Circadian IOP
Andrew Tatham on: 24-Hour efficacy of single primary selective laser trabeculoplasty versus latanoprost eye drops for Naïve primary open-angle glaucoma and ocular hypertension patients IGR 24-1/2 | 2024
Selective laser trabeculoplasty 1
Tony Realini on: Efficacy of selective laser trabeculoplasty on lowering intraocular pressure fluctuations and nocturnal peak intraocular pressure in treated primary open-angle glaucoma patients IGR 23-3 | 2023
Selective laser trabeculoplasty 2
Kaweh Mansouri on: Effectiveness and safety of VISULAS green selective laser trabeculoplasty: a prospective, interventional multicenter clinical investigation IGR 23-3 | 2023
Selective laser trabeculoplasty 3
Eytan Blumenthal on: Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial: Six-Year Results of Primary Selective Laser Trabeculoplasty versus Eye Drops for the Treatment of Glaucoma and Ocular Hypertension IGR 23-3 | 2023
Selective laser trabeculoplasty 3
Louis Pasquale & Jason Jo on: Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial: Six-Year Results of Primary Selective Laser Trabeculoplasty versus Eye Drops for the Treatment of Glaucoma and Ocular Hypertension IGR 23-3 | 2023
Post-iridotomy Cataract
Sirisha Senthil on: Cataract progression after Nd:YAG laser iridotomy in primary angle-closure suspect eyes IGR 23-1 | 2022
SLT as First-Line Treatment: Patient and Treater Perspectives
Rupert Bourne on: Facilitators and Barriers to Using Selective Laser Trabeculoplasty (SLT) as First-Line Treatment for Glaucoma: Physician and Patient Views Gathered during an Exploratory Descriptive Qualitative Study IGR 22-4 | 2022
SLT and Post-Trabeculectomy Circadian IOP
Tony Realini on: Efficacy of Selective Laser Trabeculoplasty on Circadian Intraocular Pressure Following Trabeculectomy in Advanced Primary Open-angle Glaucoma IGR 22-4 | 2022
Laser Peripheral iridotomy in Narrow Angle suspects
Wei Wang & Minguang He on: The Singapore Asymptomatic Narrow Angles Laser Iridotomy Study: Five-Year Results of a Randomized Controlled Trial IGR 22-3 | 2022
Does Anti-Inflammatory treatment affect SLT outcomes?
Andrew Tatham on: Effects of anti-inflammatory treatment on efficacy of selective laser trabeculoplasty: a systematic review and meta-analysis IGR 22-3 | 2022
PNT versus ALT
Garry Condon on: Pneumatic trabeculoplasty versus argon laser trabeculoplasty in primary open-angle glaucoma IGR 12-1 | 2010
TLT versus ALT
Jay Katz on: Titanium:Sapphire laser trabeculoplasty versus argon laser trabeculoplasty in patients with open-angle glaucoma IGR 11-3 | 2009
Pneumatic trabeculoplasty versus latanoprost
Kuldev Singh on: Pneumatic trabeculoplasty vs latanoprost as adjunctive therapy to timolol in primary open-angle glaucoma or ocular hypertension IGR 11-3 | 2009
ALT effect on latanoprost
Mark Latina on: Effect of previous argon laser trabeculoplasty on the ocular hypotensive action of latanoprost IGR 8-3 | 2006
Browse
This issue
advertisement
